ArticleOncotarget2018

Neutrophil-to-lymphocyte ratio as a predictive or prognostic factor for gastric cancer treated with nivolumab: a multicenter retrospective study.

Takatsugu Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.